Belotecan (CKD-602)

Belotecan · Chong Kun Dang Pharmaceutical Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Belotecan (CKD-602), covering 2012-04-26 to 2012-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix [Phase 2]